Select area to zoom
Created with Highcharts 11.1.0Apr '24Jul '24Oct '24Jan '25100.00112.49

Profile

Edit
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
URL https://www.novartis.com
Investor Relations URL https://www.novartis.com/investors
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Apr. 23, 2025 (est.)
Last Earnings Release Jan. 31, 2025
Next Ex-Dividend Date Mar. 12, 2025
Last Ex-Dividend Date Mar. 07, 2024

Profile

Edit
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
URL https://www.novartis.com
Investor Relations URL https://www.novartis.com/investors
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Apr. 23, 2025 (est.)
Last Earnings Release Jan. 31, 2025
Next Ex-Dividend Date Mar. 12, 2025
Last Ex-Dividend Date Mar. 07, 2024
Quickflows